Literature DB >> 1677696

Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

J E Crabtree1, J D Taylor, J I Wyatt, R V Heatley, T M Shallcross, D S Tompkins, B J Rathbone.   

Abstract

The gastric IgA response to Helicobacter pylori was examined in 100 dyspeptic patients by means of immunoblotting of supernatants from antral biopsy and gastric mononuclear cell cultures. 76 of 78 patients with chronic gastritis, 2 of 8 with reactive gastritis, and 1 of 14 subjects with normal mucosa showed positive responses. Of patients with chronic gastritis, 75%, 83%, 97% and 76%, respectively, showed responses to the 120 kDa, 90 kDa, 61 kDa, and 31 kDa proteins. None of the 19 patients with chronic gastritis who did not recognise the 120 kDa protein had peptic ulcers, whereas 25 of 57 with positive recognition had peptic ulcers (p less than 0.001). Mucosal recognition of the H pylori 120 kDa protein was also positively associated with the activity of gastritis (polymorph infiltration) (p less than 0.002) and with the extent of surface degeneration (p less than 0.01). These findings suggest that 120-kDa-positive strains of H pylori have pathogenic features associated with active gastritis and peptic ulceration. Infection with 120-kDa-negative strains may explain why peptic ulceration develops in only a proportion of subjects infected with H pylori.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677696     DOI: 10.1016/0140-6736(91)90477-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  180 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

4.  Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue.

Authors:  J E Crabtree; D Kersulyte; S D Li; I J Lindley; D E Berg
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

Review 5.  Presentation and management of Helicobacter pylori infection in childhood.

Authors:  U Blecker; N K Mittal; D I Mehta
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

6.  CagA: a role at last.

Authors:  J C Atherton
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

7.  Expression of the CagA gene ofH. pylori and application of its product.

Authors:  Feng-Chan Han; Xiao-Jun Yan; Cheng-Zhi Su
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

8.  Study of T-lymphocyte subsets, nitric oxide, hexosamine and Helicobacter pylori infection in patients with chronic gastric diseases.

Authors:  Hui Zhang; Shu-Lin Jiang; Xi-Xian Yao
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

9.  Role of a Stem-Loop Structure in Helicobacter pylori cagA Transcript Stability.

Authors:  John T Loh; Aung Soe Lin; Amber C Beckett; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

10.  Helicobacter pylori-induced interleukin-12 p40 expression.

Authors:  Eriko Takeshima; Koh Tomimori; Hiromitsu Teruya; Chie Ishikawa; Masachika Senba; Daniele D'Ambrosio; Fukunori Kinjo; Hitomi Mimuro; Chihiro Sasakawa; Toshiya Hirayama; Jiro Fujita; Naoki Mori
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.